Cadila Healthcare submits press release

24 Jul 2019 Evaluate

Cadila Healthcare has informed about submission of a copy of press release dated July 24, 2019 titled ‘Zydus has launched Ramelteon Tablets in the US upon receiving final approval from the USFDA’. The contents of the press release give full details.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

494.45 4.15 (0.85%)
31-Mar-2023 14:16 View Price Chart
Company Name CMP
Sun Pharma Inds. 989.90
Cipla 897.30
Dr. Reddys Lab 4650.85
Lupin 647.70
Zydus Lifesciences 494.45
View more..